Kenneth M. Kral
Research Triangle Park Foundation(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery, Allergic Rhinitis and Sensitization, Pulmonary Hypertension Research and Treatments
Most-Cited Works
- → Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease(2000)1,072 cited
- → Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone(2016)155 cited
- → Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma(2016)135 cited
- No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year.(2003)
- → Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events(2008)110 cited
- → Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol(2009)85 cited
- → Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily